FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, and concerns a combined therapeutic agent possessing antituberculous action. The agent is presented in a solid dosage form which contains a combination of paraaminosalicylic acid and a zinc-containing compound as an active principle, and pharmaceutically acceptable excipients. The zinc-containing compound is specified in zinc picolinate, zinc citrate, zinc acetate, zinc glycerate, zinc monomethionine, zinc aspartate, zinc hyaluronate, zinc gluconate, zinc bisvinylimidazole diacetate, zinc oxide.
EFFECT: composition is characterised by high efficacy.
8 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
MEDICINE FOR TREATING TUBERCULOSIS | 2009 |
|
RU2487702C2 |
Authors
Dates
2012-12-10—Published
2010-12-20—Filed